Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-15
2008-04-15
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S300100, C548S316400, C548S323500, C514S385000
Reexamination Certificate
active
11368990
ABSTRACT:
A compound of the formulaor a pharmaceutically acceptable salt thereof, is disclosed herein. Methods and compositions related thereto are also disclosed.
REFERENCES:
patent: 3996366 (1976-12-01), Baker et al.
patent: 4798834 (1989-01-01), Merritt et al.
patent: 5441970 (1995-08-01), Reitz et al.
patent: 5648373 (1997-07-01), Winkler et al.
patent: 5861420 (1999-01-01), Reitz et al.
patent: 5929103 (1999-07-01), Yoon et al.
patent: 5932742 (1999-08-01), Yoon et al.
patent: 6043373 (2000-03-01), Yoo et al.
patent: 6313172 (2001-11-01), Chow et al.
patent: 6534542 (2003-03-01), Chow et al.
patent: 6545182 (2003-04-01), Chow et al.
patent: 7091232 (2006-08-01), Chow et al.
patent: 7141597 (2006-11-01), Chow et al.
patent: 2002/0094998 (2002-07-01), Burke et al.
patent: 1 499 485 (1978-02-01), None
patent: WO 92/0073 (1992-01-01), None
patent: WO 99/28300 (1999-06-01), None
patent: WO 01/00586 (2001-01-01), None
patent: WO 02/36162 (2002-05-01), None
patent: WO 03/099795 (2003-12-01), None
Burke et al (2002): STN International HCAPLUS database, Columbus (OH), accession No. 2002: 353314.
Hua et al., J. Org. Chem. 1997, 62, 6888.
Conklin et al., Nature, 1993, p. 274-276, 363.
Messier et al, Pharmacol. Toxicol., 1995, p. 308-311, 76.
Dirig, et al., J. Neurosci. Methods, 1997, p. 183-191, 76.
Hargreaves, et al., Pain, 1988, p. 77-88, 32.
Kim et al., Pain, 1992, p. 355-363, 150.
Dixon et al., Ann. Rev. Pharmacol. Toxicol., 1980, p. 441-462, 20.
Jennesken et al., J. Org. Chem. 1986, 51, 2162.
Cook et al., J. Org. Chem., 1980, 45, 1046.
Kim et al., Synthesis, 1993, 283.
Kowalski et al., J. Org. Chem., 1982, 47, 5088.
Huang et al., Synthetic Communications, 1998, 28, 1197.
Ciufolini et al., J. Amer. Chem. Soc., 1991, 113, 8016.
Mancuso, Synthesis, 1981, p. 165.
Corey et al., Tetrahedron Lett., 1989, 30, 6275.
Xavier et al., Organic Synthesis, 1996, 74, 50.
Molina et al., Tetrahedron, 1995, 51, 1265.
Lemke et al., J. Med. Chem., 1977, 20, 1351.
Berque et al., J. Org. Chem., 1999, 373.
Organ et al., J. Org. Chem., 1997, 62, 1523.
Woods et al., J. Amer. Chem. Soc., 1949, 71, 2028-2031.
Horne et al., Heterocycles, 1994, 39,139.
Sosa et al., J. Org. Chem., 2002, 4498-4500, 67.
Yoon et al (1998):STN International CAPLUS data base, Columbus, Ohio, Accession No. 1998: 147327.
Jackman et al (1949): STN International CAPLUS data base, Columbus, Ohio, Accession No. 1949:2664.
Chow Ken
Garst Michael E.
Gil Daniel W.
Heidelbaugh Todd M.
Wheeler Larry A.
Allergan Inc.
Johnson Brent A.
Shameem Golam M. M.
Voet Martin A
LandOfFree
2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydr... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydr..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydr... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3938458